FLG: Could you give us an introduction of yourself and the work you do? I’m Luigi Grassi and I’m an Informatics Scientist at AstraZeneca. I’m responsible for designing and performing bioinformatical analyses of the high throughput sequencing experiments we use to characterise stable cell lines expressing biotherapeutics. FLG: What motivated you to pursue a career […]
“We are all Billionaires in Terms of our Genome Data” – Interview with Prof. Ernst Hafen, Professor of Systems Genetics, ETH Zurich
Professor Ernst Hafen is based at the Institute of Molecular Systems Biology at ETH Zurich. He studied the developmental and cell biology of fruit flies for over 30 years and now focuses on human genomic data and what it can do for health research. FLG: Could you give us an introduction of yourself and the […]
“We Are Starting to Appreciate Non-Coding DNA” – Interview with Dr Sandra Smieszek, Vanda Pharmaceuticals Inc.
Dr. Sandra Smieszek is the Head of Genetics at Vanda Pharmaceuticals Inc. She trained at the Institute for Computational Biology and has extensive experience in several aspects of human genetic studies including case control studies from clinical sequencing, whole genome explorative analyses, reverse phenotyping enabling precision medicine and pharmacogenomics.
Foundations for AI are “Critical” to our Continued Success – Interview with Dr Paul Agapow, AstraZeneca
Dr Paul Agapow is a Health Informatics Director at AstraZeneca where he explores the possibilities of biomedical Big Data and its application to personalised medicine and therapies, in particular using novel algorithms and machine learning in discovering patient subtypes and predicting outcomes.
Interview with Dr Halima Moncrieffe, Assistant Professor, Cincinnati Children’s Hospital Medical Center
Dr Halima Moncrieffe is an Assistant Professor at Cincinnati Children’s Hospital, ranked top 3 in the USA, where she combines genomics with immunology to understand medication response and disease etiology. Halima is an award-winning immunologist who’s ultimate goal is to move towards a cure for Juvenile Idiopathic Arthritis, so children can live pain-free and to their full potential
Dr Michelle Krishnan is the Translational Medicine Leading in Rare Diseases at Roche where she focuses on developing transformative therapies for rare neurodevelopmental disorders to deliver meaningful benefit for patients and families, and is responsible for the clinical development of programmes from early research to clinical trials.
Karen Lighting Jones, Head of Future Place at Roche. Back in 2016, Dame Sally Davies concluded her Chief Medical Officer annual report by saying “Genomics is not tomorrow, it’s here today. I believe genomic services should be available to more patients, whilst being a cost-effective service in the NHS”.
Interview with Dr Cecilia Domínquez Conde, Postdoctoral Fellow, Teichmann Lab, Wellcome Sanger Institute
Dr Cecilia Dominguez Conde is a postdoctoral fellow at the Teichmann Lab, Wellcome Sanger Institute. During her PhD, she discovered DOCK2 and POLD immunodeficiencies, and her current work focuses on studying the human immune system across different body sites and unravelling the clonal distributions of T and B lymphocytes. Cecilia is speaking at this years Festival of Genomics, and we found out what she’s looking forward to the most.
Interview with Prof. Diana Baralle, Professor of Genomic Medicine, Honorary Consultant Clinical Genetics, University of Southampton
Dr Diana Baralle is a professor of genomic medicine at the University of Southampton, and an honorary consultant in clinical genetics. She runs a translational research group that drives forward functional genomics to improve diagnosis, investigating novel causes for rare disorders and in particular the role of RNA and splicing in genetic disease.
Dr Alfredo Iacoangeli is a post-doctoral researcher at King’s College London whose aim is the development of a high throughput gene, environment and epigenetics database and analysis system for international ALS research. We managed to have a chat with Alfredo ahead of him speaking at the Festival of Genomics about his work, and why he’s excited to be a part of the festival this year.
Dr Gemma Chandratillake is the Education and Training Lead for the East Midlands and East of England NHS Genomic Laboratory Hub. She is passionate about the potential of genomics to improve healthcare, and works creatively to facilitate the mainstreaming of genomics within the NHS. We managed to have a chat with Gemma ahead of her […]
Dr Rona Strawbridge has been using genetics to try to understand complex diseases, who’s work has focused much on obesity, type 2 diabetes and cardiovascular disease, and more recently serious mental illness. We managed to have a chat with Rona ahead of her speaking at the Festival of Genomics about her work and why she’s excited to be speaking at the festival this year.
Interview with Dr Susie Cooke, Head of Medical Genomics at the Glasgow Precision Oncology Laboratory
Dr Susie Cooke is the Head of Medical Genomics at the Glasgow Precision Oncology Laboratory whose main interest is in facilitating the move of next-generation sequencing into the clinic to help cancer patients.
Arianne Shahvisi is a Senior Lecturer in Ethics at the Brighton and Sussex Medical School. We managed to have a chat with Arianne ahead of her speaking at the Festival of Genomics, to get her take on the ‘coloniality’ of health and how the much-hyped advent of Whole Genome Sequencing might play a role in exasperating social injustices.
Rory Collins, Principal Investigator and Chief Executive of UK Biobank leads this landmark project. We talk to him about some of the research outcomes from UK Biobank, and why he’s excited to be speaking at the Festival of Genomics this January.